Dr Reddys Laboratories RDY Cash Flow Statement (2009-2026)

NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT
Reported Financials

Dr Reddys Laboratories Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Dr Reddys Laboratories reported cash from operations of -$0.01B and free cash flow of $0.03B for the quarter ended Jun 2026, down 105.7% year over year. This cash flow statement covers 65 quarters of results from Mar 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Sep2016 Dec2016 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
0.09B0.05B0.01B0.15B0.15B0.12B0.17B0.18B0.18B0.01B-0.01B0.17B0.16B0.17B0.01B0.16B0.16B1.77B2.46B0.05B
Depreciation and DepletionDep. & Depletion
Share-based CompensationStock Comp.
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Deferred Taxes
0.04B0.04B0.02B0.04B0.06B0.05B-0.01B0.05B0.05B0.01B0.00B0.06B-0.02B-0.01B-0.00B0.06B1.46B0.02B0.01B
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.00B0.10B0.10B0.02B0.00B0.01B0.00B0.00B0.00B-0.00B0.02B0.01B-0.00B0.01B0.02B0.01B0.00B0.03B0.04B
Non-cash ItemsNon-Cash Items
Cash from OperationsCash from Ops.
0.07B0.23B0.12B0.09B0.12B0.28B0.24B0.14B0.22B0.12B0.08B0.10B0.11B0.08B0.25B0.17B0.18B0.12B0.17B-0.01B
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Depreciation & Amortization (CF)Dep. & Amort.
0.04B0.04B0.04B0.04B0.04B0.04B0.04B0.04B0.05B0.05B0.04B0.05B0.05B0.06B0.06B0.06B
Change in Working Capital
Change in ReceivablesChange Receivables
-0.10B0.08B-0.06B-0.08B-0.05B0.02B0.03B-0.06B0.09B-0.11B-0.02B-0.01B-0.04B-0.06B-0.03B0.02B
Change in InventoryChange Inventory
0.01B0.11B-0.19B-0.03B0.02B-0.02B-0.00B-0.06B-0.06B-0.06B-0.05B-0.08B-0.06B-0.07B-0.02B-0.08B
Change in Account PayablesChange Payables
0.00B-0.02B0.01B-0.01B-0.02B0.03B-0.00B0.03B0.03B0.00B-0.02B0.03B0.02B0.07B0.03B0.05B
Change in TaxesChange Taxes
-0.03B-0.03B-0.03B-0.01B-0.04B-0.03B-0.04B-0.03B-0.07B-0.07B-0.07B-0.02B-0.09B-0.04B-0.06B-0.02B
Other Working Capital ChangesOther WC Changes
-0.01B0.03B0.04B0.02B-0.09B0.02B0.04B-0.01B-0.03B0.02B0.05B-0.10B-0.01B-0.04B0.01B-0.11B
Investing Activities
Capital ExpendituresCapex
-0.04B-0.04B-0.06B-0.09B-0.08B-0.06B-0.04B
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.01B0.01B0.00B0.00B0.00B0.00B0.00B0.00B
Change in IntangiblesChange Intangibless
Acquisitions
-0.00B
Divestments
0.00B
Change in Acquisitions & DivestmentsChange Acquisitions
Cash from Investing ActivitiesCash from Investing
0.05B-0.04B-0.29B-0.06B0.07B-0.32B-0.19B-0.10B-0.05B-0.19B-0.14B-0.24B-0.23B-0.06B-0.15B-0.22B-0.11B-0.12B-0.29B0.04B
Financing Activities
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
-0.10B-0.03B0.07B-0.14B-0.15B0.01B-0.05B-0.02B-0.09B0.06B-0.01B0.11B0.19B0.01B-0.09B-0.01B-0.06B0.09B0.08B-0.08B
Debt Issuance and Repayment
Current Debt
-0.01B-0.00B0.13B0.20B0.00B
Change in Capital Stock
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Exchange Rate EffectFX Effect
-0.00B-0.00B0.01B0.01B0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B
Change in Cash
0.03B0.16B-0.10B-0.12B0.03B-0.03B-0.00B0.02B0.08B-0.20B0.12B-0.03B0.08B0.02B0.02B-0.07B0.01B0.09B-0.04B-0.04B
Beginning Cash Balance
0.19B0.07B0.09B0.17B0.16B
Free Cash FlowFCF
0.07B0.23B0.12B0.09B0.12B0.28B0.24B0.18B0.26B0.12B0.08B0.16B0.20B0.08B0.25B0.25B0.24B0.12B0.17B0.03B
Net Cash FlowNCF
0.03B0.16B-0.10B-0.12B0.03B-0.03B-0.00B0.02B0.08B-0.01B-0.07B-0.03B0.08B0.02B0.02B-0.07B0.01B0.09B-0.04B-0.04B

Dr Reddys Laboratories Cash Flow Statement API

Pull Dr Reddys Laboratories's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RDY&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY